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Background: Illegal commercial plasma and blood donation activities in the late 1980s and early 1990s caused a
large number of hepatitis C virus (HCV) infections in rural areas of China. In the present study, we aimed to
elucidate the risk factors of HCV RNA positivity and HCV genotype distribution in former blood donors.
Methods: A cross-sectional survey was carried out in a former blood donation village in rural Hebei Province, North
China. All residents were invited for a questionnaire interview and testing for HCV antibodies as well as HCV nucleic
acids. Questionnaires were administered to collect information about their personal status and commercial blood
donation history. Nested PCR was used to amplify HCV nucleic acids in C/E1 region and NS5b region followed by
genotyping and phylogenetic analysis. Univariate and multivariate logistic regression were used to analyze the
distributions of HCV genotypes in different groups.
Results: A total of 512 blood samples were collected. Anti-HCV positive were 148 (28.5%) whereas RNA positive rate
was 13.87%. Residents between 50 and 59 years old had the highest RNA positive rate (27/109, 24.77%) (P = 0.0051).
Multivariate logistic regression model analysis revealed that plasma donation (OR = 8.666, 95% CI: 1.390-54.025) was
the dominant risk factor of HCV infection. Furthermore, HCV subtypes 1b and 2a were found by genotyping and
phylogenetic analysis. 36 samples (53.73%) were subtype 1b and 31 samples (46.27%) were subtype 2a.
Conclusions: Unsafe practices during illegal plasma donation led to a high risk of HCV infection. The identification
of genotypes 1b and 2a as major HCV genotypes circulating in this region may help to predict the future burden of
HCV related diseases and facilitate better medical treatment towards HCV carriers. These results are useful for public
healthcare as well as disease control and surveillance.
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The hepatitis C virus (HCV) can cause hepatitis C,
which can range in severity from a mild illness to life-
long diseases including liver cirrhosis or liver cancer [1].
About 130 to 170 million people are chronically infected
with HCV worldwide [2,3]. In China, two nationwide
sero-epidemiological studies were conducted. According
to the latest investigation in 2006, the overall HCV
prevalence in the population of 1–59 years old was* Correspondence: zycdchp@sina.com; shengli_bi@163.com
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unless otherwise stated.0.43% (95% CI: 0.33-0.53%), with about 4.29-6.89 million
people estimated to be infected with HCV throughout
China [4,5].
Hepatitis C virus is a single-stranded and positive-
strand RNA virus. It is divided into six genotypes [6],
which differ from each other by 31-33% at the nucleo-
tide level. In addition, there are several subtypes with
20-25% differences [7]. The distribution of genotypes
and subtypes varies geographically. For example, geno-
type 1b, 2a and 2b are widely distributed worldwide [8]
whereas genotype 3 is mostly distributed in Indian sub-
continent [9,10]. Genotype 4 is found in central Africa
[11], genotype 5 is found in South Africa and genotype 6
is found in South Asia [12]. In China, studies haves is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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HCV subtypes [13-15] and other subtypes (3a, 3b, 6a,
6n and 6u) were reported from southwest part of
China [16,17].
Many residents in China rural areas were infected with
HCV due to blood selling in the late 1980s. Although a
previous study showed that the history of paid plasma
donation was responsible for the high sero-prevalence of
HCV in a village in rural Hebei Province, North China
[18], little is known about the HCV RNA positivity and
genotypes distribution in these blood donors. In the
present study, we aimed to elucidate the risk factors for
HCV RNA positivity and HCV genotypes distribution.
The results may provide important information for fu-
ture treatment of HCV related diseases and facilitate
better public health control and surveillance.
Methods
Ethics statement
The survey protocol conformed to the ethical guidelines
of the 1975 Declaration of Helsinki and was approved by
the Ethics Committee in Chinese National Institute
for Viral Disease Control and Prevention. The written
informed consent of adults and permission from the
parents of minors were obtained before the interview
and venous blood collection.
Questionnaire interview and serum sampling
The questionnaire included demographic characteristics
of the subjects and exposure histories for possible risk
factors related to HCV infection. Five milliliters of ven-
ous blood was then collected from each subject and the
serum separated. Serum samples were stored at −20°C.
A total of 520 residents were interviewed and 512
subjects accepted for venous blood collection. These
subjects included former blood donors as well as non-
blood donors, ranged in age from 3 to 89 years old; 261
were female (261/512, 50.98%) and 251 were male (251/
512, 49.02%).
Extraction and amplification of HCV RNA C/E1 region and
NS5b region
HCV RNA was extracted from 140 μl serum with
QIAamp Viral RNA Mini Kit (Qiagen, Hilden, Germany).
HCV RNA positivity was identified by nested PCR based
on C/E1 fragment. The PCR products were detected by
1% agarose gel electrophoresis for qualitative analysis. In
addition, HCV genotypes and subgenotypes were deter-
mined by using nested PCR and sequencing. Briefly, two
fragments corresponding to the HCV genome sequence nt
845–1315 on H77 (fragment C/E1) and nt 8254–8636
(fragment NS5b), were amplified respectively. A typical
amplification procedure was performed in a 50 μl reaction
volume containing 5 μl extracted HCV RNA and Taqpolymerase for 35 cycles, denaturing for 30 s at 94°C,
annealing for 30 s at 58°C, and elongation for 35 s at 72°C,
followed by a final extension at 72°C for 10 min. Standard
precautions to avoid contamination during PCR were
taken, including a negative control serum in each run.
The primers used for the amplification of fragment C/E1
and fragment NS5b was listed in Table 1.
Nucleotide sequencing of PCR products
The positive amplification products identified by agarose
gel electrophoresis were sequenced directly by the dideoxy
termination method using the Big Dye Terminator
cycle sequencing Ready Reaction Kit ver. 3.1 (Applied
Biosystems, Foster City, CA) with modifications and an
automatic sequencer (ABI PRISM 3100 Genetic Analyser;
Applied Biosystems). PCR products were sequenced in
forward and reverse directions. Sequence alignment was
performed by using the multiple-alignment algorithm in
MegAlign software (DNASTAR, Windows version 5.06,
WI).
HCV genotyping and phylogenetic analysis
The PCR product of fragment C/E1 was 471 bp and that
of fragment NS5b was 383 bp. The nucleotide sequences
obtained were aligned with HCV strains of standard ge-
notypes by the ClustalW method of MEGA software
(Version 4.0), and the Neighbor-Joining method was
used to construct a phylogenetic tree to determine the
genotypes of our samples.
Statistical analysis
Univariate and multivariate logistic regression were used
to analyze associations between HCV RNA positivity
and risk factors. Statistical analysis was performed using
SAS 9.1 (Statistical Analysis Software Institute Inc,
USA).
Results
Risk factor analysis of HCV RNA positivity in former blood
donors
HCV RNA positivity was found in 71 (71/512, 13.87%)
of the participants, with 37 (37/261, 14.18%) females and
34 (34/251, 13.55%) males. There was no statistical dif-
ference between male and female (P = 0.8365). However,
there were significant differences between age groups
(P = 0.0051). The prevalence of HCV RNA positivity was
2.08% in 3–19 years age group, 9.52% in 20–29 years age
group, 6.78% in 30–39 years age group, 14.06% in 40–49
years age group, 24.77% in 50–59 years age group and
14.29% in >60 years age group. Furthermore, there was a
statistically higher prevalence in married people (68/449,
15.14%), compared to unmarried people (3/63, 4.76%)
(P = 0.0358). There was no significant difference by oc-
cupation (P = 0.094), as the prevalence was 16.88% in
Table 1 Details of the primers for HCV amplification
Targeted fragment Name Sequence of oligonucleotide (5’-3’) Position (on H77)
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dren, and 8.55% in people whose occupation were
unknown. There was also no statistical difference by
education degree (P = 0.2540), as the prevalence was
19.80% in illiterate people, 15.60% in primary school
level, 13.04% in junior high school level, 15.63% in senior
high school level, 6.67% in kindergarten level, and 8.55%
in people whose education level was unknown (Table 2).
In regard to risk behavior variables and HCV infection,
it was important to note that the selling of blood was
prominent in this district in the late 1980s. Two types
of blood selling were found in this village, the selling of
whole blood and the selling of plasma. The results
of our questionnaire indicated 232 people had a history
of selling whole blood or plasma, with 50 serum samples
(50/232, 21.55%) positive for HCV RNA. According to
the types of blood selling, HCV RNA positivity was de-
tected in 7 subjects (7/113, 6.19%) who had sold whole
blood, 2 subjects (2/5, 40.00%) who had sold plasma, 41
subjects (41/114, 35.96%) who had sold whole blood and
plasma, and 21 subjects (21/280, 7.5%) who had neither
sold blood nor plasma. In contrast, histories of blood
transfusion, toothbrush sharing, razor sharing, thera-
peutic injection, acupuncture, surgical operations, or
tooth extraction were not risk indicators for HCV RNA
positivity in our analysis (P > 0.05) (Table 2).
From a multivariate logistic regression model of HCV
RNA positivity, histories of plasma donation (OR = 8.666,
95% CI: 1.390-54.025) and mixed donation (OR = 7.402,
95% CI: 4.301-12.740) were risk factors for HCV RNA
positivity (Table 3).
HCV genotype distribution and phylogenetic analysis
Sequencing based on C/E1 region and NS5b region of
HCV genome and the phylogenetic analysis were per-
formed successfully for 67 HCV RNA-positive samples.
The results demonstrated that 36 strains (36/67, 53.73%)
were closely related to subtype 1b, and 31 strains (31/67,
46.27%) belonged to subtype 2a. In genotype 1b isolates,
ZX2005-229 was highly homologous with reference strainAY835056 which was isolated in Kunming in 2005. Com-
paratively, ZX2005-321 in 2a isolates was strongly consist-
ent with AY834956 which was a Beijing HCV strain with
99% homology. The mean pairwise distance of these 67
strains was 0.544 substitutions per nucleotide site, with
0.060 in genotype 1b strains and 0.030 in genotype 2a
strains, respectively (Figures 1 and 2).
The phylogenetic tree based on HCV C/E1 sequences
and NS5b sequences demonstrated that 36 strains were
closely related to subtype 1b and 31 strains belonged to
subtype 2a.▲ denotes the reference isolates and the boot-
strap values were added. ♦ denotes that a HBV strain
(accession number: AF121250 & AB073821) was used as
an out-group.
Furthermore, all HCV isolates discovered in this study
were uploaded to NCBI website and the Accession Num-
bers released by NCBI were: KP721870 to KP721938 for
sequences from the amplification of C/E1 region and
KP721803 to KP721869 for sequences of NS5b region re-
spectively (Additional file 1).
By using NCBI BLAST, it was indicated that for geno-
type 1b strains, 16 strains (16/36, 44.44%) were closely
related to isolate km48 (accession number: AY835056),
with 97-99% homology, 3 strains were related to isolate
HC-P32(accession number: AF046186), 3 strains were
related to isolate HC-C2(accession number: D10934),
and the remaining 14 strains were related to other iso-
lates. For genotype 2a strains, 27 strains (27/31, 87.10%)
were closely related to isolate bj779 (accession number:
AY834956), with 96-99% homology, 4 strains (4/31, 12.90%)
were closely related to isolate ZS199 (accession number:
JX677261), GZ302 (accession number: JX521943), ZS37
(accession number: JX677354) or P012-NL(AE)_2a_1977.7
(accession number: JF722462).
Further analysis indicated HCV genotype distribu-
tion in gender and age groups. Briefly, in females, 14
strains (14/34, 41.18%) belonged to genotype 1b, and
20 strains (20/34, 58.82%) belonged to genotype 2a;
however, 22 strains (22/33, 66.67%) belonged to geno-
type 1b, and 11 strains (11/33, 33.33%) belonged to
Table 2 Univariate analysis of HCV RNA positivity and related factors
Variable No. of samples No. of positive Positive rate (%) OR (95% CI) P value
Sex 0.8365
Female 261 37 14.18 Reference
Male 251 34 13.55 0.949(0.574,1.567)
Age group 0.0051
3-19 years 48 1 2.08 Reference
20-29 years 63 6 9.52 4.947(0.575,42.555)
30-39 years 59 4 6.78 3.418(0.369,31.650)
40-49 years 128 18 14.06 7.691(0.998,59.292)
50-59 years 109 27 24.77 15.476(2.037,117.583)
60 years or older 105 15 14.29 7.833(1.004,61.138)
Marriage status 0.0358
unmarried 63 3 4.76 Reference
married 449 68 15.14 3.570(1.088,11.709)
Occupation 0.0940
Peasant 320 54 16.88 Reference
Student 59 6 10.17 0.558(0.228,1.363)
Preschool child 16 1 6.25 0.328(0.042,2.539)
Unknown 117 10 8.55 0.460(0.226,0.937)
Education degree 0.2540
Illiterate 101 20 19.80 Reference
Primary school 109 17 15.60 0.748(0.367,1.526)
Junior high school 138 18 13.04 0.607(0.303,1.219)
Senior high school 32 5 15.63 0.750(0.257,2.192)
Kindergarten 15 1 6.67 0.289(0.036,2.332)
Unknown 117 10 8.55 0.379(0.168,0.853)
Whole blood donation 0.0102
No 399 64 16.04 Reference
Yes 113 7 6.19 0.346(0.154,0.777)
Plasma donation 0.1177
No 507 69 13.61 Reference
Yes 5 2 40.00 4.232(0.695,25.785)
Mix donation* <0.0001
No 398 30 7.54 Reference
Yes 114 41 35.96 6.889(4.040,11.748)
Blood transfusion 0.6913
No 507 70 13.81 Reference
Yes 5 1 20.00 1.563(0.172,14.175)
Tooth-brush share 0.5269
No 508 70 13.78 Reference
Yes 4 1 25.00 2.086(0.214,20.334)
Razor share 0.9739
No 505 70 13.86 Reference
Yes 7 1 14.29 1.036(0.123,8.734)
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Table 2 Univariate analysis of HCV RNA positivity and related factors (Continued)
Therapeutic injection 0.5103
No 478 65 13.60 Reference
Yes 34 6 17.65 1.362(0.543,3.416)
Acupuncture 0.3609
No 493 67 13.59 Reference
Yes 19 4 21.05 1.696(0.546,5.263)
Surgery operation 0.3566
No 435 58 13.33 Reference
Yes 77 13 16.88 1.363(0.706,2.634)
Tooth extraction 0.8907
No 469 65 13.86 Reference
Yes 43 6 13.95 1.065(0.431,2.633)
*Note: Mix donation denotes whole blood donation and plasma donation.
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types statistically differed by gender (χ2 = 4.3767,
P = 0.0364), but did not significantly differ by age
(Fisher’s Exact Test, P = 0.7987).
Discussion
The total HCV RNA positive rate was much higher in
the village examined compared to the general Chinese
population [4,5] due to illegal blood donation that pre-
vailed in some areas of Hebei province in the late 1980s
[19,20]. According to results from a logistic regression
model for HCV RNA positivity, illegal blood donation,
especially plasma donation, probably led to the high
positive rate of HCV RNA. Plasma donation is a blood
collection method in which plasma is separated by cen-
trifugation and the remaining cells transfused back into
donors. This process could easily cause cross-infection
due to the poor disinfection of blood collectors and sub-
standard aseptic technology. Importantly, the HCV RNA
positive rate of plasma donors was 40% and the mixed
donors who sold whole blood and plasma had a rate of
35.96%. In the middle 1990s, the Chinese government
enacted laws to ban this type of blood donation.Table 3 Logistic regression of multi-risk factors for HCV
RNA positivity







*Note: Mix donation denotes whole blood donation and plasma donation.Although illegal blood collection agencies in this region
were banned, the prevalence of HCV RNA was still high
because of the chronic infection of HCV. Males and fe-
males had an equal positive rate of HCV RNA, which
could reflect their common behavior in selling blood.
Males and females typically sold blood together and thus
had an equal risk of being infected by blood-borne viruses.
Classified by age, residents 50–59 years old had the
highest positive rate of HCV RNA, whereas the 3–19
year old population had the lowest. Blood donors in the
late 1980s were mostly young adults responsible for sup-
porting families; therefore, they usually sold their blood
because of their poverty and low literacy.
HCV subtype 1b was predominant in this village and
the next prevalent genotype was 2a. Other subtypes were
not found in this study. Previous studies showed that ge-
notypes 1b and 2a are dominant in China, and some
studies reported the presence of genotypes 6a and 3b in
southern China [13-15]. The village in this study was lo-
cated in Hebei Province in northern China. In the late
1980s, many illegal blood agencies set up blood collec-
tion sites in this village and many local peasants went
there to sell blood. We speculate that HCV subtype 1b
and 2a were transmitted in this village and nearby re-
gions. Cross infection during the blood drawing process
likely caused the transmission of different HCV sub-
types. Reports have indicated that patients with HCV
genotype 1a or 1b had more severe liver disease and
lower response rates to interferon therapy than pa-
tients with HCV genotype 2a or 2b [17]. Compared to
genotype 1b, genotype 2a may be easier to clear spon-
taneously or by antiviral treatment. This may partly ex-
plain why the proportion of genotype 1b was slightly
higher than genotype 2a.
Interestingly, HCV subtype 2a was predominant in fe-
males and subtype 1b was predominant in males. The
Figure 1 Phylogenetic tree of HCV C/E1 sequences. Figure 2 Phylogenetic tree of HCV NS5b sequences.
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are two possibilities, firstly, only HCV RNA positive
samples were genotyped and may have limited sample
size. Secondly, females may be more susceptible to sub-
type 2a and males more vulnerable to subtype 1b though
this latter hypothesis is highly speculative.
More than 40% of subtype 1b samples were closely re-
lated to isolate km48, and 3 strains were closely related
to isolate HC-C2 [21]. Similar to previous studies
[13-15], we speculate that subtype 1b strains in our
study may be widely distributed in China. Compared to
subtype 2a strains in our study, the mean pairwise dis-
tance was higher, which indicated the genetic diversity of
subtype 1b samples in this village.
We believe most of our 2a strains may have a common
origin with isolate bj779 which was isolated from a sub-
ject in Beijing because about 87.10% of the subtype 2a
strains were closely related to isolate bj779, with a mean
pairwise distance of only 0.030. We also speculate that
subtype 2a strains similar to the isolates in our study
may be widely distributed in China [22].
Conclusion
In conclusion, unsafe practices during illegal plasma do-
nation led to a high risk of HCV infection. The present
epidemiological investigation may help to predict the fu-
ture burden of HCV related diseases and facilitate better
public health control and surveillance. Presently, those
residents positive for HCV RNA need urgent medical as-
sistance. The identification of genotypes 1b and 2a as
major HCV genotypes circulating in this region repre-
sents valuable information for future medical treatment.
It is desirable that China government may provide finan-
cial support and free healthcare to these villages, because
most of the residents in this rural district make their
living by farming and have no stable economic resources.
Additional file
Additional file 1: NCBI accession numbers of the HCV C/E1 and
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